Trained and trusted by doctors.

Dr. David Rubin helps set the standard for ulcerative colitis care. He is the lead author of the American College of Gastroenterology’s 2025 ulcerative colitis guidelines—the recommendations that guide doctors in treating adults with the disease.

As Chief of Gastroenterology, Hepatology and Nutrition at UChicago Medicine, he combines patient care with research into Crohn’s disease and ulcerative colitis, bringing deep expertise in how digestive symptoms change over time.

Dr. Suzelle Moffitt brings four decades of frontline medical experience to Throne. Practicing since 1986, her career spans patient care, health law, and service as general counsel for a regional health system—a rare combination of clinical and healthcare leadership experience.

Her conversations with her son, Throne co-founder Scott Hickle, helped spark the company. She recognized how much bowel patterns matter to patients, and how useful a reliable record could be in everyday care.

Dr. Vipul Jairath helps determine whether new treatments for Crohn’s disease and ulcerative colitis truly work. His research shapes how clinical trials are designed and how they measure meaningful improvements in patients’ lives.

A Professor of Medicine and holder of the McDonald Endowed Chair in IBD Clinical Research at Western University, he trained in gastroenterology in London and Oxford. Western credits his work with directly influencing clinical-trial design, regulatory science, and patient care.

Dr. Satish Rao pioneered biofeedback therapy for a common cause of chronic constipation—helping patients retrain the muscles needed for a bowel movement. His work has advanced how doctors understand and treat problems with the way the gut moves.

He holds the Harrison Distinguished Chair in Gastroenterology at Augusta University and co-authored the American College of Gastroenterology’s SIBO guideline. His expertise connects everyday bowel symptoms with the science of gut function.

Dr. Mark Pimentel is a pioneer in understanding the connection between gut bacteria and digestive symptoms. He is the lead author of the American College of Gastroenterology’s clinical guideline on small intestinal bacterial overgrowth (SIBO), helping define how doctors diagnose and treat the condition.

He leads the MAST research program at Cedars-Sinai, where his team investigates the microbes behind bloating, altered bowel habits, and irritable bowel syndrome—and turns those discoveries into better tests and treatments.

He also co-authored Throne’s first validation study, accepted for presentation at ACG 2026, which found that Throne’s AI reads stool form as accurately as gastroenterologists.

Dr. Fola May is working to make lifesaving colorectal cancer screening reach more people. At UCLA, she leads research on improving access to high-quality digestive care and closing gaps in cancer prevention.

She directs UCLA’s gastroenterology quality-improvement program and the May Health Services Research Laboratory, and serves as Associate Director of the UCLA Kaiser Permanente Center for Health Equity. Her work brings clinical medicine, public health, and patient advocacy together.

Dr. Aasma Shaukat helps shape how colorectal cancer is found early and prevented. She is the lead author of the American College of Gastroenterology’s 2021 colorectal cancer screening guidelines, which guide decisions about when and how people should be screened.

As Director of Outcomes Research in gastroenterology at NYU Langone, she studies how to make screening more effective, improve colonoscopy quality, and turn research into better care for patients.